Monthly Archives: February 2015

Share on Google+ February 23, 2015


Out of Control Cholesterol – The Watanabe Rabbit as an Animal Model of Familial Hypercholesterolemia

Category : APS Service Offerings, Watanabe Rabbits

What is the Watanabe Rabbit:  The Watanabe Heritable Hyperlipidemic (WHHL-MI) rabbit is an animal model of familial hypercholesterolemia, which is caused by a genetic and functional deficiency in low-density lipoprotein receptors.  This leads to a significant increase in serum cholesterol as compared to normal animals and in this sub-strain, a propensity to develop myocardial infarction.     This sample of

View Post

Tags : , , , ,

Share on Google+ February 17, 2015


No Surprises: Pre-Study meetings with Regulatory Agencies for Pivotal GLP studies

Category : Uncategorized

The recent FDA Guidance Document: Investigational Device Exemptions (IDEs) for Early Feasibility Medical Device Clinical Studies, Including Certain First in Human (FIH) Studies, issued in October of 2013 the Agency states: “Discussions with FDA on study protocols, including the evaluation of operator technique, safety outcomes, and the effects of the biological system on the device, are encouraged prior to the

View Post